Home / Respiratory system / Combinations
ATC R05DA20 · Opium Alkaloids and Derivatives · updated 2 Nov 2026
Combinations shortage
As of 2 Nov 2026, Combinations has a reported shortage in 1 of the 16 countries we track (Canada), covering 3 products from 3 companies.
Is there a Combinations shortage?
Yes. As of 2 Nov 2026, Combinations is reported short in 1 of the 16 countries we track: Canada. No company has given a return date.
Timeline
Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.
Which companies are short
products short, all countriesListed: Bausch Health BHC · NYSE / TSX
Compared with similar medicines
ATC group R05DA · Opium Alkaloids and DerivativesAffected products
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CA | PULMORPHAN PEDIATRIQUE (175 ml) | LABORATOIRE RIVA INC | 11 Apr 2014 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | TUSSODAN DM SYRUP (250 mL) | ODAN LABORATORIES LTD | 15 Apr 2016 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | COPHYLAC (15ml) | BAUSCH HEALTH, CANADA INC. | 11 Feb 2020 | not given | Active ingredient shortage Shortage of an active ingredient |
"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.
Questions
Is there a Combinations shortage?
Yes. As of 2 Nov 2026, Combinations is reported short in 1 of the 16 countries we track: Canada. No company has given a return date.
When will Combinations be back in stock?
No return date has been given; Canada: no date given. These are company estimates reported to each authority.
Why is Combinations in short supply?
The most common reason reported is: manufacturing problem. Reasons by product are listed in the table below.
Which companies have Combinations shortages?
Laboratoire Riva, Odan, Bausch Health.